Search
Cardiolipin Biosynthesis CL(20:3(11Z,14Z,17Z)/20:3(11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z))
smpdb.ca/view/SMP0248724MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/20:3(11Z,14Z,17Z)/20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
smpdb.ca/view/SMP0248864MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/20:3(11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z))
smpdb.ca/view/SMP0248890MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:3(11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
smpdb.ca/view/SMP0250226MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(20:3(11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
smpdb.ca/view/SMP0250401MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z)/20:3(11Z,14Z,17Z))
smpdb.ca/view/SMP0250603MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z)/20:2(11Z,14Z))
smpdb.ca/view/SMP0251987MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Palovarotene
go.drugbank.com/drugs/DB05467ApprovedFibrodysplasia Ossificans Progressiva (FOP), with an estimated worldwide prevalence of one in 2 million individuals, is an exceptionally rare genetic disorder. … [A244920] Palovarotene was approved for use in Canada in January 2022 for the management of heterotopic ossification (HO) in patients with FOP, representing the first global approval for any FOP therapy
De Novo Triacylglycerol Biosynthesis TG(20:1(11Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
smpdb.ca/view/SMP0016010MetabolicA triglyceride (TG, triacylglycerol, TAG, or triacylglyceride) is an ester derived from glycerol and three fatty acids. Triglycerides are the main constituents of body fat in humans and other animals, as well as vegetable fat. They are a...
De Novo Triacylglycerol Biosynthesis TG(20:1(11Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
smpdb.ca/view/SMP0022751MetabolicA triglyceride (TG, triacylglycerol, TAG, or triacylglyceride) is an ester derived from glycerol and three fatty acids. Triglycerides are the main constituents of body fat in humans and other animals, as well as vegetable fat. They are a...